Ionis and Akcea Partner to Commercialize Inotersen for hATTR

Ionis licenses to Akcea worldwide rights to inotersen and IONIS-TTR-L Rx Collaboration advances commercial readiness for planned mid-2018 inotersen launch, positioning Akcea to successfully launch two drugs for significant rare diseases this year Ion... Biopharmaceuticals, Licensing Ionis Pharmaceuticals, Akcea Therapeutics, inotersen, AKCEA-TTR-LRx
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news